Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

NCT01499043 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision.

Conditions

Prostate Cancer

Interventions

DRUG: PLX3397

Sponsor

Daiichi Sankyo

Collaborators

[object Object]